自体心包主动脉瓣新瓣叶成形术血流动力学表现优异
单中心回顾性分析103例自体心包三叶主动脉瓣重建(AVNeo,Ozaki手术)患者,平均随访426±270天。出院及术后6至12个月超声随访显示血流动力学稳定,与虚拟植入的Trifecta生物瓣相比,AVNeo平均压差更低、有效瓣口面积更大。
要点
- AVNeo术后2年内再手术率低,总体免于再手术率96.1%
- AVNeo平均压差8.5±3.7 mmHg,低于虚拟Trifecta生物瓣的10.2±2.0 mmHg
- 术后6至12个月血流动力学参数与出院时相比无变化
核心结论
- AVNeo术后2年内再手术率低,血流动力学表现优异,有效瓣口面积与平均压差在术后1年内保持稳定。
研究设计与样本
- 单中心回顾性研究,2016年10月至2019年4月共103例患者接受AVNeo手术;平均随访426±270天;平均年龄54.0±16.4岁(范围13.8-78.5岁)。
主要发现
- 全部患者完成三叶主动脉瓣重建,38例(36.9%)新建交界;平均主动脉阻断时间135±20分钟。
- 4例患者再次手术,总体免于再手术率96.1%;93.8%患者有术后6至12个月超声随访,血流动力学参数较出院时无变化。
- 与虚拟植入的Abbott/St Jude Trifecta生物瓣相比,AVNeo平均压差更低(8.5±3.7 mmHg vs 10.2±2.0 mmHg,P<.001),平均有效瓣口面积更大(2.2±0.7 cm² vs 2.1±0.4 cm²,P=.037)。
关键数值与推荐
- 主动脉瓣狭窄为最主要诊断,80例(77.7%);主动脉瓣反流23例(22.3%);二叶式主动脉瓣81例(78.6%)。
- AVNeo平均压差8.5±3.7 mmHg,虚拟Trifecta生物瓣10.2±2.0 mmHg(P<.001)。
- AVNeo平均有效瓣口面积2.2±0.7 cm²,虚拟Trifecta生物瓣2.1±0.4 cm²(P=.037)。
临床怎么用
- AVNeo可作为常规人工主动脉瓣置换的替代术式,尤其适用于希望避免人工瓣膜相关缺陷的患者。
- 术后应于出院及6至12个月行经胸超声心动图评估压差与有效瓣口面积,本研究中该时段参数稳定。
局限性
- 单中心回顾性设计,随访时间较短(平均426±270天),缺乏与真实植入Trifecta生物瓣的对照。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aortic valve neocuspidization (AVNeo) for trileaflet aortic valve reconstruction using autologous pericardium (Ozaki procedure) offers an alternative treatment modality to overcome drawbacks of conventional prosthetic aortic valve replacement. METHODS: Between October 2016 and April 2019, 103 patients underwent surgery. Mean follow-up was 426 ± 270 days. Aortic stenosis was the leading diagnosis in 80 patients (77.7%) and aortic regurgitation in 23 (22.3%), respectively. Mean age was 54.0 ± 16.4 years (range, 13.8-78.5). A bicuspid valve was found in 81 patients (78.6%). Transthoracic echocardiography was performed at discharge and at 6 to 12 months after surgery. During AVNeo surgery valve sizing for an Abbott/St Jude Trifecta bioprosthesis (virtually implanted Trifecta bioprosthesis; St Jude Medical, St Paul, MN) was performed to compare pressure gradients and effective orifice area with published data. RESULTS: Trileaflet aortic valve reconstruction was achieved in all patients. In 38 patients neocommissures were created (36.9%). Mean cross-clamp time was 135 ± 20 minutes. Four patients underwent reoperation; the overall freedom from reoperation was 96.1%. Echocardiographic 6- to 12-months follow-up after surgery was available in 93.8% of patients and did not show any change in hemodynamic parameters compared with discharge. Comparison between AVNeo and virtually implanted Trifecta Bioprosthesis revealed a significantly lower mean pressure gradient (8.5 ± 3.7 mm Hg vs 10.2 ± 2.0 mm Hg, P < .001) and higher mean effective orifice area (2.2 ± 0.7 cm2 vs 2.1 ± 0.4 cm2, P = .037) for AVNeo. CONCLUSIONS: AVNeo shows low reoperation rates after surgery within the first 2 years. The hemodynamic performance is excellent, and the effective orifice area and mean pressure gradient remain stable within the first year.
引用
- Krane M, Boehm J, Prinzing A, et al. Excellent Hemodynamic Performance After Aortic Valve Neocuspidization Using Autologous Pericardium. Ann Thorac Surg. 2020. PMID: 32540439. doi:10.1016/j.athoracsur.2020.04.108
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。